Send me a link:

*Text messaging rates may apply.

 Dow Down 1.22% Nasdaq Down 1.84%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.56 Down 0.10(3.58%) 11:55AM EDT - Nasdaq Real Time Price
Prev Close:2.65
Open:2.58
Bid:2.55 x 7100
Ask:2.56 x 2100
1y Target Est:4.90
Beta:1.64
Next Earnings Date: 4-Aug-14CTIC Earnings announcement
Day's Range:2.55 - 2.60
52wk Range:1.01 - 4.25
Volume:317,495
Avg Vol (3m):1,862,360
Market Cap:363.16M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICDown 3.58%363.16M
BMYDown 0.82%84.06B
RHHBYDown 0.72%248.42B
SNYUp 1.28%139.60B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.60
Quarterly EPS Est (Jun-14) :-0.13
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback